Schering-Plough
SGP
#545
Rank
S$58.55 B
Marketcap
N/A
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Schering-Plough was a major American pharmaceutical company that developed and marketed a range of prescription drugs. In 2009, Schering-Plough was acquired by Merck & Co. in a $41 billion USD deal.

Schering-Plough (SGP) - Total debt

Total debt on the balance sheet as of December 2008 : S$10.36 Billion

According to Schering-Plough's latest financial reports the company's total debt is S$10.36 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Schering-Plough - Total debt on balance sheet (from 1996 to 2008)

Total debt by year

Year Total debt Change
2008-12-31S$11.69 B
2006-12-31S$4.07 B-33.48%
2005-12-31S$6.12 B-5.26%
2004-12-31S$6.46 B10.79%
2003-12-31S$5.83 B-22.06%
2002-12-31S$7.48 B112.77%
2001-12-31S$3.51 B-22.84%
2000-12-31S$4.55 B
1998-12-31S$3.38 B-18.15%
1997-12-31S$4.13 B166.18%
1996-12-31S$1.55 B